Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin
Main Author: | Sang Youl Rhee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2023-11-01
|
Series: | Diabetes & Metabolism Journal |
Online Access: | http://www.e-dmj.org/upload/pdf/dmj-2023-0351.pdf |
Similar Items
-
Pharmacokinetics and Tissue Distribution of Enavogliflozin in Mice and Rats
by: Minyeong Pang, et al.
Published: (2022-06-01) -
Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species
by: Mingui Jang, et al.
Published: (2024-01-01) -
Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
by: Young Sang Lyu, et al.
Published: (2024-02-01) -
Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
by: Kyung Ah Han, et al.
Published: (2023-11-01) -
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
by: Min-Soo Kim, et al.
Published: (2023-03-01)